UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | K | L | M | O | R | S | T | W
Number of items: 30.

A

ABBASI, AM; CHESTER, KA; MACPHERSON, AJS; BOXER, GM; BEGENT, RHJ; MALCOLM, ADB; (1992) LOCALIZATION OF CEA MESSENGER-RNA BY INSITU HYBRIDIZATION IN NORMAL COLONIC MUCOSA AND COLORECTAL ADENOCARCINOMAS. J PATHOL , 168 (4) 405 - 411.

Abbasi, AM; Chester, KA; Macpherson, AJS; Boxer, GM; Begent, RHJ; Green, AJ; Malcolm, DB; (1992) Localization of cea messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas. The Journal of Pathology , 168 (4) pp. 404-411.

B

BISSET, GMF; PAWELCZAK, K; JACKMAN, AL; CALVERT, AH; HUGHES, LR; (1992) SYNTHESES AND THYMIDYLATE SYNTHASE INHIBITORY ACTIVITY OF THE POLY-GAMMA-GLUTAMYL CONJUGATES OF N-[5-[N-(3,4-DIHYDRO-2-METHYL-4-OXOQUINAZOLIN-6-YLMETHYL)-N-METHYLAMINO]-2-THENOYL]-L-GLUTAMIC ACID (ICI D1694) AND OTHER QUINAZOLINE ANTIFOLATES. J MED CHEM , 35 (5) 859 - 866.

BOXER, GM; BEGENT, RHJ; KELLY, AMB; SOUTHALL, PJ; BLAIR, SB; THEODOROU, NA; DAWSON, PM; (1992) FACTORS INFLUENCING VARIABILITY OF LOCALIZATION OF ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN (CEA) IN PATIENTS WITH COLORECTAL-CARCINOMA - IMPLICATIONS FOR RADIOIMMUNOTHERAPY. BRIT J CANCER , 65 (6) 825 - 831.

C

Calvert, AH; Newell, DR; Gore, ME; (1992) Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin? Semin Oncol , 19 (1 Suppl ) pp. 155-163.

Chester, KAB; R, HJ; (1992) 8th International Hammersmith Meeting On Advances in application of monoclonal-antibodies in clinical oncology. European Journal of Cancer , 28A pp. 606-608.

Cooper, DP; O'Connor, PJ; Thatcher, N; Lee, SM; (1992) DNA methylation and clinical response following alkylating agent chemotherapy for malignant melanoma. In: (pp. 31-).

D

DOWSETT, M; MEHTA, A; KING, N; SMITH, IE; POWLES, TJ; STEIN, RC; COOMBES, RC; (1992) AN ENDOCRINE AND PHARMACOKINETIC STUDY OF 4 ORAL DOSES OF FORMESTANE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS. EUROPEAN JOURNAL OF CANCER , 28A (2-3) pp. 415-420. 10.1016/S0959-8049(05)80065-6.

DOWSETT, M; STEIN, RC; COOMBES, RC; (1992) AROMATIZATION INHIBITION ALONE OR IN COMBINATION WITH GNRH AGONISTS FOR THE TREATMENT OF PREMENOPAUSAL BREAST-CANCER PATIENTS. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY , 43 (1-3) pp. 155-159. 10.1016/0960-0760(92)90201-S.

F

FISHER, RA; PARADINAS, FJ; NEWLANDS, ES; BOXER, GM; (1992) GENETIC-EVIDENCE THAT PLACENTAL SITE TROPHOBLASTIC TUMORS CAN ORIGINATE FROM A HYDATIDIFORM MOLE OR A NORMAL CONCEPTUS. BRIT J CANCER , 65 (3) 355 - 358.

G

GRAHAM, MA; NEWELL, DR; FOSTER, BJ; GUMBRELL, LA; JENNS, KE; CALVERT, AH; (1992) CLINICAL PHARMACOKINETICS OF THE ANTHRAPYRAZOLE CI-941 - FACTORS COMPROMISING THE IMPLEMENTATION OF A PHARMACOKINETICALLY GUIDED DOSE ESCALATION SCHEME. CANCER RES , 52 (3) 603 - 609.

H

HARRIS, AL; HOCHHAUSER, D; (1992) MECHANISMS OF MULTIDRUG RESISTANCE IN CANCER-TREATMENT. ACTA ONCOLOGICA , 31 (2) 205 - 213.

HARTLEY, JA; BINGHAM, JP; SOUHAMI, RL; (1992) DNA-SEQUENCE SELECTIVITY OF GUANINE-N7 ALKYLATION BY NITROGEN MUSTARDS IS PRESERVED IN INTACT-CELLS. NUCLEIC ACIDS RES , 20 (12) 3175 - 3178. Gold open access

J

Johnson, PWM; Whelan, JS; Longhurst, S; Norton, A; Matthews, J; Rohatiner, AZS; Lister, TA; (1992) B-2 microglobulin (B-2M): a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. In:

K

KONINGS, WN; TOLNER, B; SPEELMANS, G; ELFERINK, MGL; DEWIT, JG; DRIESSEN, AJM; (1992) ENERGY TRANSDUCTION AND TRANSPORT PROCESSES IN THERMOPHILIC BACTERIA. J BIOENERG BIOMEMBR , 24 (6) 601 - 609.

L

Lee, SM; Rafferty, J; Fan, CY; Thatcher, N; Margison, GP; (1992) Regional and cellular heterogeneity of expression of 06-alkylguanine-DNA alkyltransferase in melanoma. In: (Proceedings) Oral presentation. 1992 AACR Annual Meeting/83nd Annual Meeting, San Diego, CA.. (pp. 547-). Proc Am Assoc Cancer Res

Lee, SM; Rafferty, JA; Elder, RH; Fan, C-Y; Bromley, M; Harris, M; Thatcher, N; ... Margison, GP; + view all (1992) Immunohistological examination of the inter- and intracellular distribution of 06-alkylguanine-DNA-alkyltransferase in human liver and melanoma. In: (pp. 33-).

M

Macpherson, AJS; Chester, KA; Robson, L; Bjarnson, I; Malcolm, ADB; Peters, TJ; (1992) Increased expression of C-MYC protooncogene in biopsies of ulcerative-colitis and Crohns colitis. Gut , 33 (5) pp. 651-656.

Macpherson, AJS; Mayall, TP; Chester, KA; Abbasi, A; Forgacs, I; Malcolm, ADB; Peters, TJ; (1992) Mitochondrial gene-expression in the human gastrointestinal-tract. Journal of Cell Science , 102 (2) pp. 307-314.

O

OCONNOR, BM; JACKMAN, AL; CROSSLEY, PH; FREEMANTLE, SE; LUNEC, J; CALVERT, AH; (1992) HUMAN LYMPHOBLASTOID-CELLS WITH ACQUIRED-RESISTANCE TO C2-DESAMINO-C2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID - A NOVEL FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITOR. CANCER RES , 52 (5) 1137 - 1143.

R

Rohatiner, AZS; Bassan, R; Batista, R; Kingston, JE; Amess, J; Carter, M; Oza, AM; ... Lister, TA; + view all (1992) UNSPECIFIED In: (Proceedings) High dose cytosine arabinoside in the treatment of acute lymphoblastic leukaemia. Meeting Proceedings, Acute Leukemias III - Prognostic factors and treatment strategies,. : Munster.

Rohatiner, AZS; Battista, R; Bassan, R; Love, S; Oza, AM; Whelan, JS; Lim, J; ... D'Emillio, ; + view all (1992) Short term therapy for acute myelogenous leukaemia. Leukemia , 6 (S2) pp. 85-88.

S

STEIN, RC; JOSEPH, AEA; MATLIN, SA; CUNNINGHAM, DC; FORD, HT; COOMBES, RC; (1992) A PRELIMINARY CLINICAL-STUDY OF GOSSYPOL IN ADVANCED HUMAN CANCER. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 30 (6) pp. 480-482. 10.1007/BF00685601.

SUNTERS, A; SPRINGER, CJ; BAGSHAWE, KD; SOUHAMI, RL; HARTLEY, JA; (1992) THE CYTOTOXICITY, DNA CROSS-LINKING ABILITY AND DNA-SEQUENCE SELECTIVITY OF THE ANILINE MUSTARDS MELPHALAN, CHLORAMBUCIL AND 4-[BIS(2-CHLOROETHYL)AMINO] BENZOIC-ACID. BIOCHEM PHARMACOL , 44 (1) 59 - 64.

T

TOLNER, B; POOLMAN, B; KONINGS, WN; (1992) CHARACTERIZATION AND FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI OF THE SODIUM PROTON GLUTAMATE SYMPORT PROTEINS OF BACILLUS-STEAROTHERMOPHILUS AND BACILLUS-CALDOTENAX. MOL MICROBIOL , 6 (19) 2845 - 2856.

TOLNER, B; VANDERREST, ME; SPEELMANS, G; KONINGS, WN; (1992) SODIUM COUPLED TRANSPORT IN BACTERIA. In: QUAGLIARIELLO, E and PALMIERI, F, (eds.) MOLECULAR MECHANISMS OF TRANSPORT. (pp. 43 - 50). ELSEVIER SCIENCE PUBL B V

W

WILLEMS, JL; LANGENBERG, JP; VERSTRAETE, AG; DELOOSE, M; VANHAESEBROECK, B; GOETHALS, G; BELPAIRE, FM; ... COLARDYN, F; + view all (1992) PLASMA-CONCENTRATIONS OF PRALIDOXIME METHYLSULFATE IN ORGANOPHOSPHORUS POISONED PATIENTS. ARCHIVES OF TOXICOLOGY , 66 (4) pp. 260-266. 10.1007/BF02307171.

Whelan, JS; Smith, TA; Rohatiner, A; Lister, T; Meuth, M; (1992) A potential molecular basis of resistance to cytosine arabinoside in acute leukaemia. In:

Whelan, JS; Smith, TA; Rohatiner, AZS; Lister, TA; Meuth, M; (1992) UNSPECIFIED In: (Proceedings) Resistance to cytosine arabinoside: are mutations in CTP synthetase an important mechanism? Meeting Proceedings, Acute Leukemias III - Prognostic factors and treatment strategies,. : Munster.

Whelan, JS; Smith, TA; Rohatiner, AZS; Lister, TA; Meuth, M; (1992) Resistance to cytosine arabinoside: are mutations in CTP synthetase an important mechanism? In:

This list was generated on Sun Apr 15 01:55:11 2018 BST.